drugset / Trial / NCT02866435

Identifying the Brain Substrates of Hypoglycemia Unawareness in Type 1 Diabetes

NCT02866435

Phase 0 Completed 27 enrolled University of Minnesota
RandomizedParallel-groupDouble-blindBasic science

Summary

The purpose of this study is to investigate how the brain responds to low blood glucose in non-diabetic individuals. The ultimate goal is to understand the brain substrates of hypoglycemia unawareness, a condition that can occur in patients with type1 diabetes undergoing insulin treatment.In the present study, the investigators focus on differences between two groups of non-diabetic subjects: one group who experienced two episodes of hypoglycemia the day prior to the study (and supposedly developed some level of unawareness to hypoglycemia), and one group who did not. In this study, a 3 tesla MRI scanner is used to acquire brain images. The imaging system is identical to the ones used in hospitals.

Timeline

Start
2016-11
Primary completion
2019-09-30
Completion
2019-12-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Glucose Unknown 20 % Intravenous
Subject Insulin Protein / enzyme biologic Intravenous
Background POTASSIUM PHOSPHATE, UNSPECIFIED FORM Unknown Intravenous

Indications